Inventor
LEVINE BRUCE L
US25 patents
⚠️ This page may combine multiple inventors who share the name “LEVINE BRUCE L”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
UNIV PENNSYLVANIA
21 patentsUS9540445B2Jan 10, 2017
Compositions and methods for treatment of cancer
UNIV PENNSYLVANIA99 citations99
US9518123B2Dec 13, 2016
Compositions and methods for treatment of cancer
UNIV PENNSYLVANIA92 citations99
US9481728B2Nov 1, 2016
Compositions and methods for treatment of cancer
UNIV PENNSYLVANIA100 citations99
US9464140B2Oct 11, 2016
Compositions and methods for treatment of cancer
UNIV PENNSYLVANIA117 citations99
US9328156B2May 3, 2016
Use of chimeric antigen receptor-modified T cells to treat cancer
UNIV PENNSYLVANIA127 citations99
US9102760B2Aug 11, 2015
Compositions for treatment of cancer
UNIV PENNSYLVANIA254 citations99
US9102761B2Aug 11, 2015
Compositions for treatment of cancer
UNIV PENNSYLVANIA250 citations99
US9101584B2Aug 11, 2015
Methods for treatment of cancer
UNIV PENNSYLVANIA250 citations99
US8975071B1Mar 10, 2015
Compositions for treatment of cancer
UNIV PENNSYLVANIA255 citations99
US8916381B1Dec 23, 2014
Methods for treatment of cancer
UNIV PENNSYLVANIA276 citations99
US8911993B2Dec 16, 2014
Compositions for treatment of cancer
UNIV PENNSYLVANIA474 citations99
US8906682B2Dec 9, 2014
Methods for treatment of cancer
UNIV PENNSYLVANIA507 citations99
US9572836B2Feb 21, 2017
Methods for assessing the suitability of transduced T cells for administration
UNIV PENNSYLVANIA33 citations94
US10273300B2Apr 30, 2019
Methods of making chimeric antigen receptor-expressing cells
UNIV PENNSYLVANIA26 citations92
US10829735B2Nov 10, 2020
Methods for improving the efficacy and expansion of immune cells
UNIV PENNSYLVANIA14 citations82
US10603378B2Mar 31, 2020
Toxicity management for anti-tumor activity of CARs
UNIV PENNSYLVANIA10 citations82
US11648270B2May 16, 2023
Methods for treating chronic lymphocytic leukemia (CLL)
UNIV PENNSYLVANIA1 citations71
US11273219B2Mar 15, 2022
Toxicity management for anti-tumor activity of CARs
UNIV PENNSYLVANIA4 citations71
US9994818B2Jun 12, 2018
ICOS critically regulates the expansion and function of inflammatory human Th17 cells
UNIV PENNSYLVANIA2 citations71
US11001805B2May 11, 2021
ICOS critically regulates the expansion and function of inflammatory human Th17 cells
UNIV PENNSYLVANIA0 citations61
US10046008B2Aug 14, 2018
Methods for treating chronic lymphocytic leukemia (CLL)
UNIV PENNSYLVANIA1 citations60